Home Infusion Therapy Market: Global Industry Analysis and Forecast 2022-2029

Home Infusion Therapy Market is anticipated to reach US$ 59.75 Bn by 2029 from US$ 25.93 Bn in 2021 at a CAGR of 11 % during a forecast period. The giving of drugs or biologicals to an individual at home by subcutaneous or intravenous infusion treatment. Equipment like pump, drugs such as immune globulin and antivirals, and supplies such as catheters and tubing are all needed to do the home infusion. Nursing services are also required to educate & coach patients on how to safely manage infusion medications at home. Global Home Infusion Therapy MarketTo know about the Research Methodology :- Request Free Sample Report

Home Infusion Therapy Market Dynamics

Home infusion treatment devices are effectively meeting the needs of complex patients, which is reflected in the overall market's growth. Patients are moving away from traditional therapies and into specialized infusion therapy, such as home infusion therapy. According to the National Infusion Association, hospitalization is more costly than home infusion therapy. Additionally, a growing elderly population, a larger frequency of long-term ailments, and the novelty of such therapeutic gadgets are all contributing to the overall market's growth. In contrast, dangers connected with pharmaceutical delivery, irregularities in infusion device operation, erroneous infusion device use, and complex reimbursement regulations may stifle market growth. On the other hand, most poor countries lack a payment framework and policy for home care, which drives up out-of-pocket costs. This, along with a lack of adequate medical help and restricted resources in a home environment, might make the market difficult to navigate. Nonetheless, the growing number of medical breakthroughs, as well as the introduction of equipment such as portable infusion pumps and others, are expected to provide attractive growth opportunities for the market. Furthermore, the current coronavirus epidemic, which has forced individuals to stay at home, is expected to boost the growth of the home infusion therapy market. The market for home infusion treatment might rise as people's lifestyles change. Secondly, an increase in the diabetes population and lower treatment costs would propel this market forward. These infusion treatments can cure a wide range of severe medical problems and illnesses, reducing hospital stays and, as a result, treatment costs. Home infusion treatments are safer since the medications are administered under the supervision of a physician. This will also help to boost the market's growth. Overdosing pharmaceuticals can result in dangerous situations, as well as a shortage of qualified nurses in developed and developing markets, as well as irregularities in the operation of infusion devices and incorrect usage of infusion devices, all of which might hamper the market's growth.

Home Infusion Therapy Market Segmentation Analysis

By Application, during the forecast period, the anti-infective therapy segment is likely to dominate the worldwide home infusion therapy market. One of the most commonly prescribed home infusion therapies is anti-infective therapy. However, there are a few hazards associated with this type of therapy that can be mitigated by a multidisciplinary strategy that includes strict patient selection criteria, an organized follow-up procedure, and a focus on patient education. Catheter sepsis, cellulitis, chronic urinary tract infections (UTI), pneumonia, cystic fibrosis (CF), and fungal infections are all examples of illnesses that can be treated with home infusion anti-infective medication. Furthermore, this yearly rise is expected to result in 3-5 million cases of severe disease and 290 000-650 000 fatalities globally. As a result, the market examined is likely to be driven by an increase in the incidence of various infectious illnesses across established and emerging markets.

Home Infusion Therapy Market Regional Insight

Because of the increased need for infusion therapies in the region, North America dominates the global market for infusion therapy devices. In addition, factors such as an increasing senior population and higher rates of cancer, AIDS, and diabetes in North America are driving demand for infusion therapy devices. According to the American Cancer Society, there were approximately 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States in 2021. Breast cancer, lung cancer, prostate cancer, colorectum cancer, bladder cancer, and skin cancer are the most frequent malignancies in the United States. Additionally, due to lower costs and increased patient mobility, there is a growing migration from acute care to home care settings, which is likely to stimulate development even further. Advances in the healthcare industry, as well as the deployment of more advanced medical items, are boosting regional product demand. The increased acceptability of non-hospital treatments and the vast base of geriatric customers who require infusion therapies regularly are driving demand for home infusion therapy devices in Europe. Moreover, throughout the forecast period, the market in Asia is expected to grow at the quickest rate. Aside from that, the Asia Pacific market is expected to grow rapidly throughout the forecast period, owing to the rising incidence of diabetes, heart disease, cancer, and other chronic illnesses in the region. Report Objectives: • Landscape analysis of the Home Infusion Therapy Market • competitive benchmarking • Past and current status of the industry with the forecasted market size and trends • Evaluation of potential key players that include market leaders, followers, and new entrants • Technology trends • Potential impact of micro-economic factors of the market • External and Internal factors affecting market have been analysed The report also helps in understanding the Home Infusion Therapy Market dynamics, structure by analysing the market segments and project the Home Infusion Therapy Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Home Infusion Therapy Market make the report investor’s guide.

Home Infusion Therapy Market Scope: Inquiry Before Buying

Home Infusion Therapy Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 25.93 Bn.
Forecast Period 2022 to 2029 CAGR: 21  % Market Size in 2029: US $ 59.75 Bn.
Segments Covered: by Product • Infusion Pump • Intravenous Sets • IV Cannulas • Needleless Connectors
by Application • Anti-infective • Hydration Therapy • Chemotherapy • Enteral Nutrition • Parenteral Nutrition • Specialty Pharmaceuticals • Other

Home Infusion Therapy Market by Region

• North America • Asia pacific • Europe • Middle East and Africa • South America

Home Infusion Therapy Market: Key Players

• Braun Melsungen AG • Abbott Laboratories • Fresenius Kabi AG • Baxter • Care Fusion Corporation • Hospira, Inc. • AccuVein • Stryker Corporation • Vuetek Scientific • Smiths medical • IV-EYE • Veinlite • Aetna • Continuum Rx • Evena • Carecentrix • Bristol-Myers Squibb • Axela Care • Tricare • Eli Lilly and Company Frequently Asked Questions 1. What is the projected market size & growth rate of Home Infusion Therapy Market? Ans- Home Infusion Therapy Market was valued at USD 25.93 Billion in 2021 and is projected to reach USD 59.75 Billion by 2029, growing at a CAGR of 11 % during the forecast period. 2. What are the key driving factors for the growth of Home Infusion Therapy Market? Ans- Home infusion treatment devices are effectively meeting the needs of complex patients, which is reflected in the overall market's growth. 3. Which Region accounted for the largest Home Infusion Therapy Market share? Ans- North America dominates the global market for infusion therapy devices. 4. What makes Europe a Lucrative Market for Home Infusion Therapy Market? Ans- The increased acceptability of non-hospital treatments and the vast base of geriatric customers who require infusion therapies regularly are driving demand for home infusion therapy devices in Europe. 5. What are the top players operating in Home Infusion Therapy Market? Ans- American Process Inc., Borregaard, CelluForce, DIACEL FINECHEM LTD, Sappi Ltd, Oji Holdings Corporation, and Innventia.
1. Global Home Infusion Therapy Market : Research Methodology 2. Global Home Infusion Therapy Market : Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Home Infusion Therapy Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Home Infusion Therapy Market : Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Home Infusion Therapy Market Segmentation 4.1 Global Home Infusion Therapy Market, By Product (2021-2029) • Infusion Pump • Intravenous Sets • IV Cannulas • Needleless Connectors 4.2 Global Home Infusion Therapy Market, By Application (2021-2029) • Anti-infective • Hydration Therapy • Chemotherapy • Enteral Nutrition • Parenteral Nutrition • Specialty Pharmaceuticals • Other 5. North America Home Infusion Therapy Market (2021-2029) 5.1 North American Home Infusion Therapy Market, By Product (2021-2029) • Infusion Pump • Intravenous Sets • IV Cannulas • Needleless Connectors 5.2 North America Home Infusion Therapy Market, By Application (2021-2029) • Anti-infective • Hydration Therapy • Chemotherapy • Enteral Nutrition • Parenteral Nutrition • Specialty Pharmaceuticals • Other 5.3 North America Home Infusion Therapy Market, by Country (2021-2029) • United States • Canada • Mexico 6. Asia Pacific Home Infusion Therapy Market (2021-2029) 6.1. Asia Pacific Home Infusion Therapy Market, By Product (2021-2029) 6.2. Asia Pacific Home Infusion Therapy Market, By Application (2021-2029) 6.2. Asia Pacific Home Infusion Therapy Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Home Infusion Therapy Market (2021-2029) 7.1. Middle East and Africa Home Infusion Therapy Market, By Product (2021-2029) 7.2. Middle East and Africa Home Infusion Therapy Market, By Application (2021-2029) 7.3. Middle East and Africa Home Infusion Therapy Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Home Infusion Therapy Market (2021-2029) 8.1. Latin America Home Infusion Therapy Market, By Product (2021-2029) 8.2. Latin America Home Infusion Therapy Market, By Application (2021-2029) 8.3 Latin America Home Infusion Therapy Market, by Country (2021-2029) • Brazil • Argentina • Rest Of Latin America 9. European Home Infusion Therapy Market (2021-2029) 9.1. European Home Infusion Therapy Market, By Product (2021-2029) 9.2. European Home Infusion Therapy Market, By Application (2021-2029) 9.3 European Home Infusion Therapy Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Braun Melsungen AG 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Braun Melsungen AG 10.3. Abbott Laboratories 10.4. Fresenius Kabi AG 10.5. Baxter 10.6. Care Fusion Corporation 10.7. Hospira, Inc. 10.8. AccuVein 10.9. Stryker Corporation 10.10. Vuetek Scientific 10.11. Smiths medical 10.12. IV-EYE 10.13. Veinlite 10.14. Aetna 10.15. Continuum Rx 10.16. Evena 10.17. Carecentrix 10.18. Bristol-Myers Squibb 10.19. Axela Care 10.20. Tricare 10.21. Eli Lilly and Company

About This Report

Report ID 69992
Category Healthcare
Published Date Oct 2022
Updated Date
Contact Us